For local public health agencies and healthcare providers only:
For general questions about COVID-19:
Novermber 3, 2021: CDC Authorizes Pfizer Vaccine for use in children ages 5 - 11
October 20, 2021: Ordering is OPEN for Pediatric Pfizer Vaccine
September 23, 2021: What You Need To Know About Colorado Vaccine Mandates
September 3, 2021: Colorado Medical Society commends new COPCPVAX Grant Program
September 2, 2021: AMA: Time to mandate COVID-19 vaccination is now
August 26, 2021: COVID-19 vaccine news roundup
August 23, 2021: Comirnaty and Pfizer-BioNTech COVID-19 Vaccine
August 23, 2021: What FDA’s full approval of Pfizer-BioNTech COVID-19 vaccine means
April 21, 2021: CMS Virtual Town Hall: Vaccine Access and Legislative Update
The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus (2019-nCoV) that was first identified in Wuhan City, Hubei Province, China in December 2019. Since then, more than 30,000 cases have been reported, with the vast majority in mainland China. In this article, the Colorado Department of Public Health and Environment provides guidance to providers on identifying, reporting, and treating a patient suspected of having 2019 novel coronavirus. Read more here.
American Medical Association COVID-19 Resource Center
the American Medical Association has created a COVID-19 Resource Center, a curation of comprehensive CDC, JAMA and WHO resources, that will quickly help physicians prepare their practices, address patient concerns and answer the most pressing questions. It will be updated regularly.
JAMA: 2019 novel coronavirus resource center
The Journal of the American Medical Association has created a respository of information on coronavirus diagnosis and treatment that includes podcasts, interactive graphics, CME and other scientific resources, CDC guidance and WHO guidance. Access the resource center here.
Centers for Medicare and Medicaid Services
The federal CMS issued frequently asked questions and answers (FAQs) for health care providers regarding Medicare payment for laboratory tests and other services related to the 2019-Novel Coronavirus (COVID-19).
Texas Medical Association
The Texas Medical Association has gathered information and resources on coronavirus, most uniquely the "decision tree" graphic that shows a flowchart of how to respond should a patient present with symptoms of the 2019 novel coronavirus or if he or she may have been exposed. Access the resource page here.
AACME: Novel coronavirus education resources
The Accreditation Council for Continuing Medical Education has created a Novel Coronavirus Education Resources webpage that includes a list of accredited continuing education activities and additional resources that can help the provider and clinician community respond to the novel coronavirus public health emergency. Access the resource page here.
Federal CMS: Code for coronavirus lab test
The Centers for Medicare and Medicaid Services developed a new HCPCS code for providers and laboratories to test patients for SARS-CoV-2. This code will allow those labs conducting the tests to bill for the specific test instead of using an unspecified code, which means better tracking of the public health response for this particular strain of the coronavirus to help protect people from the spread of this infectious disease.
Health care providers who need to test patients for Coronavirus using the Centers for Disease Control and Prevention 2019 Novel Coronavirus Real Time RT-PCR Diagnostic Test Panel may bill for that test using the newly created HCPCS code (U0001). The Medicare claims processing system will be able to accept this code on April 1, 2020, for dates of service on or after Feb. 4, 2020.
For more information:
Have a resource to add to this page? Send it to email@example.com.